Advanced search
Publication Cover
Journal of Nutritional & Environmental Medicine Volume 8, 1998 - Issue 2
Journal homepage
2
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Hormonal Manipulation of Breast Cancer

ANN JOHNSON Breast Study Centre, Mount Vernon and Watford Hospitals NHS Trust, Mount Vernon Hospital, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK
Pages 177-186 | Published online: 13 Jul 2009

  • Guidance on the creation of evidence-linked guidelines for the Clinical Oncology Network (COIN) of the Royal College of Radiologists. COIN Project Office, North Middlesex Hospital, London N18 1QX, UK.
  • Cook DJ, Guyatt GH, Laucapis A, et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992; 102 Suppl: 305-11.
  • Thomlinson RH. Measurement and management of carcinoma of the breast. Clin Radiol 1982; 33: 481-93.
  • Cheung CWD, Johnson AE. Carcinoma of the breast: measurement and the management of treatment. 1. The value of the data. Br J Radiol 1991; 64: 29-36.
  • Cheung CWD, Johnson AE. Carcinoma of the breast: measurement and the management of treatment. II. The regression of tumours. Br J Radiol 1991; 64: 121-32.
  • Johnson AE, Bennett MH, Cheung CWD, et al. The management of individual breast cancers. The Breast 1995; 4: 100-11.
  • Raymond WA, Leong AS-Y. Oestrogen receptor, staining of paraffin-embedded breast carcinomas following short fixation in formalin: a comparison with cytosolic and frozen section receptor analyses. J Pathol 1990; 160: 295-303.
  • Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-8.
  • Johnson AE, Shekhdar J. Interval Cancers in the NHS Breast Screening Programme. Br J Radiol 1995, 68: 862-9.
  • McGuire WL. Physiological principles underlying endocrine therapy of breast cancer. In: McGuire WL, ed. Breast Cancer Advances in Research and Treatment. I. Current Approaches to Therapy. New York: Plenum, 1977; 217-62.
  • Welboum RB. Endocrine aspects of advanced mammary cancer. Ann RCS 1967; 41 Suppl: 131-42.
  • Bulbrook RD, Greenwood FC, Hayward JL. Lancet 1960; 1: 1154-7.
  • Folca PJ, Glascock RF, Irvine W. Studies with tritium-labelled hexoestrol in advanced breast cancer. Lancet 1961; 2: 796-8.
  • Nicholson RI, McClelland RA, Gee JMW. Steroid hormone receptors and their clinical significance in cancer. J Clin Pathol 1995; 48: 890-5.
  • Robertson JFR. Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 1996; 73: 5-12.
  • McGuire WL, Carbone PP, Sears ME, et al. Estrogen receptors in human breast cancer: an overview, In: McGuire WL, Carbone PP, Vollmer EP, eds. Estrogen Receptors in Human Breast Cancer. New York: Raven Press, 1975; 17-30.
  • McGuire WL, Horwitz KB, Zava DT, et al. Hormones in breast cancer: update 1978. Metabolism 1978; 27: 487-501.
  • Allegra JC, Lippman ME, Thompson EB, et al. Estrogen receptor status is the most important prognostic variable in predicting response to endocrine therapy in metastatic breast cancer. Eur J Cancer 1.980; 16: 323-31.
  • DeSombre ER, Green GL, Jensen EV. Estrophilin and endocrine responsiveness of breast cancer. In: McGuire WL, ed. Hormones, Receptors and Breast Cancer. New York: Raven Press, 1978; 1.
  • McGuire WL. The usefulness of steroid hormone receptors in the management of primary and advanced breast cancer. In: Mouridsen HT, Palshof T, eds. Breast Cancer-Experimental and Clinical Aspects. Proceedings of Second EORTC Breast Cancer Working Conference. Oxford: Pergamon Press. Published as Supplement No. 1, 1980 to the Eur J Cancer Clin Oncol, pp. 39-43.
  • Cole MP, Jones CTA, Todd IDH. A new anti-oestrogenic agent in late breast cancer. An early appraisal of IC146474. Br J Cancer 1971; 25: 270-5.
  • Baum M. Selection for endocrine treatment. Reviews on Endocrine-Related Cancer, Suppl. 16, ICI Pharmaceuticals, UK, 1985, pp. 33-8.
  • Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1-15.
  • Nicholson RI, Bouzubar N, Walker KJ, et al. Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. Eur J Cancer 1991; 27: 908-13.
  • Charlton BG, Taylor PRA, Proctor SJ. The PACE (population-adjusted clinical epidemiology) strategy: a new approach to multi-centred clinical research. Q J Med 1997; 90: 147-51.
  • Bloom HJG. Prognosis in carcinoma of the breast. Br J Cancer 1950; 4: 259-88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.